EXOZ
eXoZymes, Inc.Insider Trades
News
accessnewswire.comeXoZymes Inc. Announces Closing of $6 Million Public Offeringaccessnewswire.comJun 17
accessnewswire.comeXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrantsaccessnewswire.comJun 8
accessnewswire.comeXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Programaccessnewswire.comMay 7
accessnewswire.comeXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcastaccessnewswire.comApr 10
accessnewswire.comeXoZymes Provides Fourth Quarter and Full Year 2025 Updateaccessnewswire.comMar 31